Fingerprint
Dive into the research topics where Linjie Luo is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
CDK2 inhibitor BLU-222 synergizes with CDK4/6 inhibitors in drug resistant breast cancers through p21/p27 induction
Luo, L., Wang, Y., Bui, T., Jiang, X., Chen, M. K., Rao, X., Mohammadhosseinpour, S., Li, M., Kim, S., Kim, R. Y., Kamaliasl, S., Ulizio, C. W., Tsavachidis, S., Navarro-Yepes, J., Kettner, N. M., Wingate, H., Meric-Bernstam, F., Hunt, K. K., Wang, J. & Faia, K. & 1 others, , Dec 2026, In: Nature communications. 17, 1, 619.Research output: Contribution to journal › Article › peer-review
Open Access3 Link opens in a new tab Scopus citations -
CDK2 inhibition enhances CDK4/6 inhibitor antitumor activity in comprehensive breast cancer PDX model screen
House, N. C., Chen, M. M., Khazaei, S., Brown, V., Ramsden, P., Peng, D. H., Moore, S., Yuan, L., Wu, R., Wang, F., Luo, L., Feng, N., Bristow, C. A., Yap, T. A., Keyomarsi, K., Marszalek, J. R., Ribich, S., Rinne, M. L., Muthuswamy, L. B. & Faia, K. L., Dec 2025, In: npj Breast Cancer. 11, 1, 135.Research output: Contribution to journal › Article › peer-review
Open Access4 Link opens in a new tab Scopus citations -
Rb1 deficiency induces synthetic lethality with ATR and PKMYT1 coinhibition in breast cancer cell lines and patient-derived xenografts
Jiang, X. T., Chen, M. K., Lee, J., Rao, X., Wang, Y., Luo, L., Wang, J., Hunt, K. K. & Keyomarsi, K., Dec 24 2025, In: Science translational medicine. 17, 830, eadx6797.Research output: Contribution to journal › Article › peer-review
-
Single-cell RNA sequencing identifies molecular biomarkers predicting late progression to CDK4/6 inhibition in patients with HR+/HER2- metastatic breast cancer
Luo, L., Yang, P., Mastoraki, S., Rao, X., Wang, Y., Kettner, N. M., Raghavendra, A. S., Tripathy, D., Damodaran, S., Hunt, K. K., Wang, J., Li, Z. & Keyomarsi, K., Dec 2025, In: Molecular cancer. 24, 1, 48.Research output: Contribution to journal › Article › peer-review
Open Access34 Link opens in a new tab Scopus citations -
Targeting CDK2 and other novel cell cycle targets for breast cancer therapy
Chen, M. K., Luo, L., Massoumi, N. & Keyomarsi, K., 2025, In: Expert Opinion on Therapeutic Targets. 29, 7, p. 435-456 22 p.Research output: Contribution to journal › Review article › peer-review
Open Access8 Link opens in a new tab Scopus citations